Učitavanje...
Optimized TrkB Agonist Ameliorates Alzheimer’s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase
[Image: see text] BDNF/TrkB neurotropic pathway, essential for neural synaptic plasticity and survival, is deficient in neurodegenerative diseases including Alzheimer’s disease (AD). Our previous works support that BDNF diminishes AD pathologies by inhibiting delta-secretase, a crucial age-dependent...
Spremljeno u:
| Izdano u: | ACS Chem Neurosci |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Chemical Society
2021
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8269693/ https://ncbi.nlm.nih.gov/pubmed/34106682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.1c00181 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|